Biotechnology Index NYSE ETF (FBT)

$144.47 1.04 (0.71%)

11:56 EST FBT Stock Quote Delayed 30 Minutes

7 Biotech Stocks To Buy For Profit From The Vaccine Crunch

By Tezcan Gecgil, InvestorPlace Contributor Oct 7, 2020

As the race to develop a vaccine continues, these biotech stocks could be high risk, high return propositions.

3 Healthcare ETFs to Buy for Health and Safety

7 Biotech ETFs to Buy Now For Covid-19 And Beyond

7 Equal-Weighted Index Funds to Buy for 2020 and Beyond

More Articles

Volume:

Previous Close -

Market Cap 15.24M

PE Ratio -

EPS -

Volume (Avg. Vol.) 33,724

Day's Range $144.17 - $146.43

52-Week Range $145.40 - $186.51

Dividend & Yield N/A (N/A)

FBT Stock Predictions, Articles, and Biotechnology Index NYSE ETF News

From InvestorPlace
From the Web

7 of the Best Biotech ETFs

By Todd Shriber, InvestorPlace Contributor Feb 27, 2019

Amid ongoing industry consolidation, attractive valuations and a strong broad market, catalysts are in place for more upside for biotech ETFs.

7 Biotech ETFs to Consider for 2019

By Todd Shriber, InvestorPlace Contributor Nov 20, 2018

Biotech ETFs lagged in 2018, but that doesn't mean there aren't healthcare funds to consider for 2019.

9 ETF Winners From 9-Year Bull Run

By Zacks Investment Research Mar 9, 2018

We have presented a bunch of top-performing ETFs of the nine-year bull market that will continue to outperform in the coming months. Compare Brokers...

4 Hot Sector ETFs Springing Up to Rank #1

By Zacks Investment Research Mar 8, 2018

A number of funds in their respective sectors have seen their Ranks surging to the top hierarchy and could make great spring picks. Compare Brokers...

The 10 Best ETFs of January 2018

By Robert Waldo, InvestorPlace Senior Web Editor Feb 2, 2018

These were the some of the best ETFs in January. Each outperformed the S&P 500 by at least 5% or more. Here's what investors need to know about each ETF.

Sector ETF and Stock Winners in the 10 Years Since the Great Recession

By Zacks Investment Research Dec 7, 2017

While most of the sectors have flourished over the past decade, consumer discretionary and information technology have led the way .

Is Now the Time to Buy Into These 5 Biotech ETFs?

By Zacks Investment Research Mar 14, 2017

After a painful 2016, biotech stocks are recovering this year. What lies ahead? Let's look at 5 biotech ETFs to find out

Bet on a Bounce with These Biotech ETFs

By Todd Shriber, InvestorPlace Contributor Oct 13, 2015

Biotech stocks may have taken a beating lately, but that may just make these biotech ETFs more of a bargain.

The Best Way to Buy Biotech Stocks: A Heated Debate

By Todd Shriber, InvestorPlace Contributor Aug 28, 2015

Among ETFs that hold biotech stocks, XBI looks like a winner, holding the advantages of equal-weighting and exposure to some potential highfliers.

The Best ETFs of 2014

By Aaron Levitt, InvestorPlace Contributor Dec 30, 2014

Sure, you're going to see biotech atop this list of the year's best ETFs ... but a couple of market areas boasted funds with head-scratchingly high returns.

Looking For the Best ETFs to Buy? Read On.

By Will Ashworth, InvestorPlace Contributor Oct 1, 2014

The best ETFs in Q3 were sectors and countries rather than broader markets. Three ETFs from China, Middle East and biotech come to mind.

3 Ways to Play Healthcare’s Hot Stocks

By David Fabian, FMD Capital Management Jul 24, 2014

Broad plays on healthcare stocks have done well historically, but investors can get some significant juice out of more targeted plays.

Biotech ETFs That Outperformed Last Week

From Talk Markets Dec 20, 2021

Though the broad U.S. market saw a tumultuous ride last week with most of the sectors in red, biotechnology was the biggest gainer.

Biotech ETFs To Benefit From Latest Booster Update

From Talk Markets Aug 21, 2021

Vaccine makers like Moderna and Pfizer have reasons to cheer the update with regard to the application of boosters. The U.S. government announced plans to make COVID-19 vaccine boosters available from Sept. 20 onward. Here's ETFs that may benefit.

Q2 Growth 'Nothing Short Of Virtuous': Economist

From Benzinga Jul 29, 2021

The coronavirus pandemic that began in 2020 and is persisting today has led many investors to hold poor market expectations. But maybe they shouldn’t be so pessimistic. What...

Top-Performing Biotech ETFs of Last Week

From Talk Markets Jun 15, 2021

Investors may want to tap the bullishness in the biotech sector with the best biotech ETFs of last week.

5 Top ETFs With Exposure To Biogen

From Talk Markets Jun 7, 2021

Here is a look at five ETFs with large exposure to Biogen shares.

5 Top ETFs With Exposure To Biogen

From Benzinga Jun 7, 2021

For the first time in 18 years, there was a new treatment for Alzheimer’s Disease approved by the FDA. Aducanumab from Biogen Inc (NASDAQ: BIIB) was approved as a drug that...